Latest News

BEIJING, China – Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease marked by the thickening and scarring of lung tissue with unclear etiology. Affecting around five million people worldwide, IPF causes severe respiratory problems and greatly diminishes the quality of life. Despite ongoing medical research, the exact...
Bristol, UK – While several trials have shown that substantial weight loss using diet and lifestyle can reverse type 2 diabetes, new research published in Diabetologia (the journal of the European Association of the Study of Diabetes) is among the first to show the subsequent impact of remission on cardiovascular...
Toyoake, Japan – Parkinson’s disease (PD), the second most common neurodegenerative disorder globally, has long baffled scientists with its progressive nature and debilitating effects on motor function.A recent study from the School of Medicine at Fujita Health University has brought new insights into the metabolic disruptions experienced by patients with...
CARLSBAD, Calif. — ALZpath, Inc., a leader in Alzheimer’s diagnostics, announced new findings published online today in JAMA Neurology showing that its proprietary blood-based biomarker assay for phosphorylated tau at residue 217 (pTau217) delivers high diagnostic accuracy and consistency in identifying amyloid and tau in the brain. The article, “Diagnostic Accuracy...
Portsmouth, UK – A new study involving University of Portsmouth researchers has uncovered key molecular defects underlying a rare developmental brain condition in children. The research team, led by Dr Reza Maroofian, Dr Rauan Kaiyrzhanov and Professor Henry Houlden at University College London Queen Square Institute of Neurology, investigated the...
Turku, Finland – Researchers have discovered a crucial protein, TLNRD1, that could help us better understand and treat Cerebral Cavernous Malformations (CCM) disease. This condition causes blood-filled lesions in the brain, leading to seizures, neurological problems, and, in severe cases, strokes. A team of scientists from Åbo Akademi University and...
COLORADO SPRINGS, Colo. — The evolution of retinoblastoma treatment over the past 15 years has resulted in a higher likelihood of vision preservation without compromising survival, according to research released today at the Society of NeuroInterventional Surgery’s (SNIS) 21st Annual Meeting. Retinoblastoma, a rare eye cancer that affects young children,...